CIK 0001847367 · <br>Emerging growth company
ALUMIS INC.
Sign in to watch- Ticker
- ALMS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 650-231-6625
- Business address
- 280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- FL2021-001, Inc.
- Open-market buys, last 90 days
- $10,726,255
- in 1 filing
- Open-market sales, last 90 days
- $1,037,650
- in 7 filings
Net +$9,688,605. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- AKKARAJU SRINIVAS +$9.7M Director sold 4% of stake
- Schroer John R. −$5K Chief Financial Officer sold 3% of stake
- Hardiman Roy C. −$4K Chief Business & Strategy Ofcr sold <1% of stake
- Goldstein David M −$4K Chief Scientific Officer sold 2% of stake
- Bradley Mark Christopher −$4K Chief Development Officer sold 1% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-07-01 | Schroer John R. Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −17,171 | 0 | ||
| 2024-07-01 | Schroer John R. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +17,171 | 17,171 | ||
| 2024-07-01 | Schroer John R. Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −59,516 | 0 | ||
| 2024-07-01 | Schroer John R. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +59,516 | 59,516 | ||
| 2024-07-01 | Schroer John R. Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −55,978 | 0 | ||
| 2024-07-01 | Schroer John R. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +55,978 | 55,978 | ||
| 2024-07-01 | Schroer John R. Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −70,588 | 0 | ||
| 2024-07-01 | Schroer John R. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +70,588 | 70,588 | ||
| 2024-07-01 | Hardiman Roy C. Chief Business & Legal Officer | Returned to the company | −175,401 | 0 | ||
| 2024-07-01 | Hardiman Roy C. Chief Business & Legal Officer | Grant or award | +175,401 | 175,401 | ||
| 2024-07-01 | Hardiman Roy C. Chief Business & Legal Officer | Returned to the company | −6,417 | 0 | ||
| 2024-07-01 | Hardiman Roy C. Chief Business & Legal Officer | Grant or award | +6,417 | 6,417 | ||
| 2024-07-01 | Hardiman Roy C. Chief Business & Legal Officer | Returned to the company · Stock Option (Right to Buy) | −42,780 | 0 | ||
| 2024-07-01 | Hardiman Roy C. Chief Business & Legal Officer | Grant or award · Stock Option (Right to Buy) | +42,780 | 42,780 | ||
| 2024-07-01 | Hardiman Roy C. Chief Business & Legal Officer | Returned to the company · Stock Option (Right to Buy) | −151,871 | 0 | ||
| 2024-07-01 | Hardiman Roy C. Chief Business & Legal Officer | Grant or award · Stock Option (Right to Buy) | +151,871 | 151,871 | ||
| 2024-07-01 | Hardiman Roy C. Chief Business & Legal Officer | Returned to the company · Stock Option (Right to Buy) | −14,973 | 0 | ||
| 2024-07-01 | Hardiman Roy C. Chief Business & Legal Officer | Grant or award · Stock Option (Right to Buy) | +14,973 | 14,973 | ||
| 2024-07-01 | Hardiman Roy C. Chief Business & Legal Officer | Returned to the company · Stock Option (Right to Buy) | −30,642 | 0 | ||
| 2024-07-01 | Hardiman Roy C. Chief Business & Legal Officer | Grant or award · Stock Option (Right to Buy) | +30,642 | 30,642 |
Page 16 of 21 · 405 trades